Na Yeon Kim

Insider Reports History

Location
Boston, MA
Signature
/s/ Phillip D. Torrence, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Na Yeon Kim:

Company Role Class Num Shares Value Price $ Report Date Ownership
NeuroBo Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 101,459 $317,567 $3.13 27 Jul 2023 Direct
NeuroBo Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 96,351 $301,579 $3.13 27 Jul 2023 Held by The E&Healthcare Investment Fund II
NeuroBo Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 62,159 $194,558 $3.13 27 Jul 2023 Held by The E&Healthcare Investment Fund No. 7
NeuroBo Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 37,373 $116,977 $3.13 27 Jul 2023 Held by The E&Healthcare Investment Fund No. 6
NeuroBo Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock 4,671 $14,620 $3.13 27 Jul 2023 Held by E&Investment Inc.

Insider Reports Filed by Na Yeon Kim

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MTVA NeuroBo Pharmaceuticals, Inc. 27 Jul 2023 2 $0 4 Director, 10%+ Owner 28 Jul 2023, 06:08
MTVA NeuroBo Pharmaceuticals, Inc. 26 Jul 2022 1 $0 4/A Director, 10%+ Owner 28 Jul 2023, 06:02
MTVA NeuroBo Pharmaceuticals, Inc. 09 Jun 2022 1 $0 4 Director, 10%+ Owner 13 Jun 2022, 16:14